The impact of short-chain fatty acid–producing bacteria of the gut microbiota in hyperuricemia and gout diagnosis
暂无分享,去创建一个
A. Burguete-García | J. Vázquez-Mellado | R. Sánchez-Sánchez | B. Palacios-González | A. Lagunas-Martínez | L. Silveira | J. Fernández-Torres | A. López-Reyes | G. Martínez-Nava | C. Pineda | Y. Zamudio-Cuevas | K. Martínez-Flores | Carlos Martinez-Armenta | G. E. Jimenez-Gutierrez | Laura E Martínez-Gómez | C. Lozada-Pérez | M. C. Camacho-Rea | A. Francisco-Balderas | L. Sànchez-Chapul | E. O. Méndez-Salazar | Citlalli Orbe-Orihuela | Dafne L Guido-Gómora
[1] Connie M. Rhee,et al. Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease , 2022, JAMA network open.
[2] Min-Chan Park,et al. Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development , 2022, Yonsei medical journal.
[3] Zhaoxin Lu,et al. The potential of probiotics in the amelioration of hyperuricemia. , 2022, Food & function.
[4] H. Park,et al. Treatment of gouty arthritis is associated with restoring the gut microbiota and promoting the production of short-chain fatty acids , 2021, Arthritis Research & Therapy.
[5] R. Terkeltaub,et al. Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts , 2021, Arthritis & rheumatology.
[6] G. Martínez-Nava,et al. Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development , 2021, Rheumatology International.
[7] Runyue Huang,et al. Metagenomic analysis revealed the potential role of gut microbiome in gout , 2021, npj Biofilms and Microbiomes.
[8] J. Dopazo,et al. Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism , 2021, Molecular Medicine.
[9] Y. Zhu,et al. The gut microbiome as non-invasive biomarkers for identifying overweight people at risk for osteoarthritis. , 2021, Microbial pathogenesis.
[10] Timothy L. Tickle,et al. Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.
[11] Ying-Ying Zheng,et al. Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased , 2021, Bioengineered.
[12] Jianwei Chen,et al. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice , 2020, European Journal of Nutrition.
[13] K. Verbeke,et al. Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.
[14] Peter Meinicke,et al. Tax4Fun2: prediction of habitat-specific functional profiles and functional redundancy based on 16S rRNA gene sequences , 2020, Environmental Microbiome.
[15] T. Joshi,et al. Proteomic and metabolomic analysis of Azospirillum brasilense ntrC mutant under high and low nitrogen conditions. , 2020, Journal of proteome research.
[16] M. Sawhney,et al. Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: Meta-analysis of correlational evidence. , 2019, Journal of diabetes and its complications.
[17] Hong Gu,et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities , 2019, Scientific Reports.
[18] Francesco Asnicar,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[19] M. Lanaspa,et al. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD , 2019, Nature Reviews Nephrology.
[20] Xiangfang Zeng,et al. Bridging intestinal immunity and gut microbiota by metabolites , 2019, Cellular and Molecular Life Sciences.
[21] C. Elson,et al. Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis , 2018, Genes & Immunity.
[22] Zhijun Xie,et al. Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout , 2017, Front. Microbiol..
[23] Y. Saeki,et al. Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine , 2016, Arthritis & rheumatology.
[24] Canghai Li,et al. Uric acid transporters hiding in the intestine , 2016, Pharmaceutical biology.
[25] Paul J. McMurdie,et al. DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.
[26] Jiachao Zhang,et al. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans , 2016, Scientific Reports.
[27] L. Joosten,et al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases , 2015, Annals of the rheumatic diseases.
[28] Richard J. Johnson. Why focus on uric acid? , 2015, Current medical research and opinion.
[29] A. Ogdie,et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.
[30] J. Nicoli,et al. A Role for Gut Microbiota and the Metabolite‐Sensing Receptor GPR43 in a Murine Model of Gout , 2015, Arthritis & rheumatology.
[31] J. Bunge,et al. Estimating diversity via frequency ratios , 2014, Biometrics.
[32] Mina Rho,et al. Stability of Gut Enterotypes in Korean Monozygotic Twins and Their Association with Biomarkers and Diet , 2014, Scientific Reports.
[33] Maria Pia Conte,et al. Dysbiotic Events in Gut Microbiota: Impact on Human Health , 2014, Nutrients.
[34] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[35] F. Duca,et al. Gut microbiota, nutrient sensing and energy balance , 2014, Diabetes, obesity & metabolism.
[36] Xueming Zhao,et al. Deregulation of purine pathway in Bacillus subtilis and its use in riboflavin biosynthesis , 2014, Microbial Cell Factories.
[37] Susan Holmes,et al. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.
[38] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[39] Y. Shinohara,et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia , 2012, Nature Communications.
[40] R. Tibshirani,et al. Strong rules for discarding predictors in lasso‐type problems , 2010, Journal of the Royal Statistical Society. Series B, Statistical methodology.
[41] Hong Wang,et al. Uric acid, hyperuricemia and vascular diseases. , 2012, Frontiers in bioscience.
[42] S. Miehlke,et al. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.
[43] P. Chou,et al. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. , 2000, The Journal of rheumatology.